Preparation of inactivated vaccines against alphaviruses using Semliki Forest virus-white mouse as a model. II. Evaluation of formalin-inactivated vaccines treated with tri(n-butyl)phosphate and-or saponin and properties of the inactivated virus.
D000596:Amino Acids; D000818:Animals; D001102:Arbovirus Infections / Q000517:prevention & control; D002250:Carbon Radioisotopes; D002499:Centrifugation, Density Gradient; D004195:Disease Models, Animal; D005069:Evaluation Studies as Topic; D005557:Formaldehyde / Q000494:pharmacology*; D007120:Immunochemistry; D008055:Lipids / Q000032:analysis; D008722:Methods; D051379:Mice; D012367:RNA, Viral / Q000032:analysis; D012503:Saponins / Q000494:pharmacology*; D012672:Semliki forest virus / Q000032:analysis / Q000187:drug effects / Q000276:immunology*; D013229:Stearic Acids; D013501:Surface-Active Agents / Q000494:pharmacology*; D014316:Tritium; D014529:Uridine; D014611:Vaccination; D014765:Viral Vaccines
D000596:Amino Acids; D002250:Carbon Radioisotopes; D008055:Lipids; D012367:RNA, Viral; D012503:Saponins; D013229:Stearic Acids; D013501:Surface-Active Agents; D014765:Viral Vaccines; D014316:Tritium; D005557:Formaldehyde; D014529:Uridine